Aziz-ur-Rehman .1
,
S Gul1,
MA Abbasi1,
K Nafeesa1,
MN Akhtar3,
KM Khan2,
I Ahmad3,
S Afzal3
1Department of Chemistry, Government College University, Lahore-54000;
2HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270;
3Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur-63100, Pakistan;
4Faculty of Industrial Sciences & Technology, University of Malaysia Pahang (UMP), Lebuhraya Tun Razak 26300 Gambang, Kuantan, Malaysia.
For correspondence:- Aziz-ur-Rehman .
Email: azizryk@yahoo.com Tel:+9242111000010
Received: 18 November 2014
Accepted: 23 September 2015
Published: 29 November 2015
Citation:
. A, Gul S, Abbasi M, Nafeesa K, Akhtar M, Khan K, et al.
Synthesis and evaluation of some new 5-substituted-1,3,4-oxadiazol-2yl-4-(morpholin-4yl sulfonyl)benzyl sulfides as antibacterial agent. Trop J Pharm Res 2015; 14(11):2047-2053
doi:
10.4314/tjpr.v14i10.14
© 2015 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To synthesise a new series of 5-substituted-1,3,4-Oxadiazol-2yl-4-(morpholin-4yl sulfonyl)benzyl sulfide and evaluate their antibacterial activity.
Methods: Different organic acids were converted consecutively into corresponding esters, hydrazides and 5-substituted-1,3,4-Oxadiazol-2-thiols (4a-e). The targets, 6a-e were synthesized by stirring 4a-e with 4-(4-(bromomethyl)phenylsulfonyl) morpholine (5) in the presence of N,N-dimethylformamide (DMF) and sodium hydride (NaH). All the structures were elucidated by modern spectroscopic techniques and screened against bacteria using standard procedure and ciprofloxacin drug as positive control.
Results: The yield of the synthesized compounds (4a-e and 6a-e) were moderate (65 - 90 %). Compounds 6a-e had antibacterial activity against Pseudomonas aeruginosa, Bacillis subtilis and Staphylococcus aureus while some had activity against the other bacteria used. One of the compounds, 6b, exhibited significant activity against all the bacterial strains, i.e., S. typhi (-), E. coli (-), K. pneumoniae (-), P. aeruginosa (-), B. subtilis (+) and S. aureus (+) with MIC (μM) values of 11.01 ± 0.31, 15.37 ± 3.33, 16.11 ± 1.14, 9.70 ± 1.96, 10.01 ± 2.70 and 9.15 ± 0.29, respectively. However, none of the compounds had any inhibitory activity against any bacteria as high as that of ciprofloxacin.
Conclusion: Five new compounds with antibacterial activities have been synthesized. Their potential as therapeutic agents is, however, yet to be evaluated.
Keywords: 1,3,4-Oxadiazole, Benzyl sulfide, 4-(4-(bromomethyl)phenylsulfonyl)morpholine, Spectral analysis, Antibacterial activity